Physician profile
Mark J Steinberg
NPI 1477622801
$12,904.23
in general payments reported to CMS, 2019-2025
9 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical Oral and Maxillofacial Pathology provider received nationally (typical 2025 total: $90.97).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $1,714 · 2021: $783 · 2022: $126 · 2023: $545 · 2024: $9,282 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,172 · Food and Beverage: $1,306 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,171.83 |
| Food and Beverage | $1,305.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Implants North America INC | $10,915.49 | 2019-2025 | Inverta |
| Zimvie INC. | $1,166.15 | 2024 | |
| Henry Schein, INC. | $500.00 | 2024 | |
| Depuy Synthes Sales INC. | $109.72 | 2019 | |
| Dentsply Sirona INC | $90.91 | 2024 | Q-Mix |
| Kls-Martin L.P. | $62.27 | 2021-2023 | |
| Geistlich Pharma, North America, INC. | $24.59 | 2021 | |
| Biohorizons Implant Systems INC. | $17.88 | 2024 | Biohorizons |
| Benco Dental Supply Co. | $17.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.